DADC
OXFD

D.A. Davidson & Co’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

D.A. Davidson & Co’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-11,106
Closed -$172K – 2470
2017
Q1 		$172K Buy
+11,106
New +$159K ﹤0.01% 1007

Other funds holding OXFD

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

D.A. Davidson & Co's OXFD Position: Q2 2017 in Review

D.A. Davidson & Co sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2017, closing a stake of 11,106 shares — an estimated $172K sold.

D.A. Davidson & Co first reported a position in OXFD in Q1 2017 and held it in 1 quarter. The position peaked at $172K in Q1 2017. 75 funds tracked by Wall St. Rank hold OXFD as of Q2 2017.

  • D.A. Davidson & Co reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 11,106 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2017, an estimated $172K.
  • D.A. Davidson & Co first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2017 and held it in 1 quarter.
  • D.A. Davidson & Co's Oxford Immunotec Global PLC Ordinary Shares position peaked at $172K in Q1 2017.
  • 75 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2017.

Based on D.A. Davidson & Co's 13F filing for Q2 2017, filed 11 Aug 2017.